In 2022, the operating profit of biopharmaceutical company Celltrion amounted to around 647 billion South Korean won. This represents a significant decrease compared to the previous year. Celltrion is one of the most successful pharmaceutical businesses in South Korea.
Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Premium Statistic Market cap of select pharma companies with strong pipeline 2017
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2023
About the region
10
- Premium Statistic Sales revenue Samsung Biologics 2015-2023
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
Selected statistics
9
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
Other regions
10
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada by age 2021
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Sold packaging units of phytopharmaceuticals in Germany in 2022, by sales channel
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Main pharmacies in Mexico 2019, by size
Related statistics
10
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2023
Further related statistics
10
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Sinopharm 2010-2022
- M&A capacities - changes for the global pharma industry 2008-2015
- Pfizer's ad spending 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Celltrion. (September 26, 2023). Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won) [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/
Celltrion. "Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won)." Chart. September 26, 2023. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/
Celltrion. (2023). Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won). Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/
Celltrion. "Operating Profit of Celltrion from 2017 to 2022 (in Billion South Korean Won)." Statista, Statista Inc., 26 Sep 2023, https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/
Celltrion, Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won) Statista, https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/ (last visited June 10, 2024)
Operating profit of Celltrion from 2017 to 2022 (in billion South Korean won) [Graph], Celltrion, September 26, 2023. [Online]. Available: https://www.statista.com/statistics/1155744/south-korea-celltrion-operating-profit/